您的位置: 首页 > 农业专利 > 详情页

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
专利权人:
Oryzon Genomics S.A.
发明人:
Alberto Ortega Muñoz,Matthew Colin Thor Fyfe,Marc Martinell Pedemonte,Iñigo Tirapu Fernandez De La Cuesta,Maria de los Ángeles Estiarte-Martinez
申请号:
US14848649
公开号:
US09708309B2
申请日:
2015.09.09
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Thus, in one specific aspect the invention relates to formulas (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充